Hypermarcas SA operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hypermarcas SA with three other
pharmaceutical manufacturers in Latin America:
Genomma Lab Internacional Sab De Cv
sales of 11.32 billion Mexican Pesos [US$620.59 million]
of which 59%
Diagnosticos Da America SA
(3.04 billion Brazilian Reals [US$911.50 million]
of which 100%
was servi os auxiliares), and
(2.10 billion Brazilian Reals [US$628.33 million]
of which 83%
was Diagnostic Medicine).
Hypermarcas SA reported sales of 3.29 billion Brazilian Reals (US$985.83 million)
December of 2016.
increase of 11.2%
versus 2015, when the company's sales were 2.96 billion Brazilian Reals.
Despite this increase, sales are still
below the level achieved in 2014, when Hypermarcas SA
reported sales of 4.68 billion Brazilian Reals.
The sales level in 2016 was fairly close to the level five years ago: in 2011, Hypermarcas SA had sales
of 3.32 billion Brazilian Reals.